Last reviewed · How we verify

Vaccine for intramuscular injection — Competitive Intelligence Brief

Vaccine for intramuscular injection (Vaccine for intramuscular injection) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: vaccine. Area: Infectious Diseases.

phase 3 vaccine Infectious Diseases Biologic Live · refreshed every 30 min

Target snapshot

Vaccine for intramuscular injection (Vaccine for intramuscular injection) — Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products. This vaccine stimulates the body's immune system to produce a specific response against the target pathogen.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Vaccine for intramuscular injection TARGET Vaccine for intramuscular injection Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products phase 3 vaccine
Comirnaty BNT162b2 (tozinameran) Pfizer Inc. marketed vaccine SARS-CoV-2 virus 2021-08-23
Prevnar 20 pneumococcal 20-valent conjugate vaccine (PCV20) Pfizer Inc. marketed Pneumococcal conjugate vaccine Streptococcus pneumoniae capsular polysaccharides (20 serotypes) 2021-06-08
MMR vaccine (Priorix) MMR vaccine (Priorix) GlaxoSmithKline marketed Live attenuated vaccine
Gardasil 9 rescue dose Gardasil 9 rescue dose Boston Medical Center marketed Recombinant HPV vaccine Human papillomavirus types 6, 11, 16, 18, 31, 33, 45, 52, 58
Vaxigrip® Vaxigrip® National University Hospital, Singapore marketed Inactivated influenza vaccine
Standard vaccination schedule Standard vaccination schedule Universidade Federal de Goias marketed vaccine

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

Sponsor landscape (vaccine class)

  1. Pfizer · 20 drugs in this class
  2. Sanofi Pasteur, a Sanofi Company · 20 drugs in this class
  3. GlaxoSmithKline · 12 drugs in this class
  4. Merck Sharp & Dohme LLC · 12 drugs in this class
  5. Centers for Disease Control and Prevention · 9 drugs in this class
  6. Zhejiang Provincial Center for Disease Control and Prevention · 7 drugs in this class
  7. Jiangsu Province Centers for Disease Control and Prevention · 6 drugs in this class
  8. Beijing Center for Disease Control and Prevention · 6 drugs in this class
  9. International Centre for Diarrhoeal Disease Research, Bangladesh · 5 drugs in this class
  10. Sinovac Biotech Co., Ltd · 4 drugs in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Vaccine for intramuscular injection — Competitive Intelligence Brief. https://druglandscape.com/ci/vaccine-for-intramuscular-injection. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: